Censa Pharmaceuticals Inc. — Form D
Censa Pharmaceuticals Inc. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2016-04-19. The offering totals $5.0M, of which $1.5M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2016-04-19
- Form: D
- Accession: 0001605796-16-000005
- Industry: Pharmaceuticals
- Exemptions: 05, 06b
- Total offering: $5.0M
- Amount sold: $1.5M
- Remaining: $3.5M
- Minimum investment: $20K
- Investors: 11
- Date of first sale: 2016-04-04
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-261604
Issuer
- Name: Censa Pharmaceuticals Inc.
- CIK: 0001672520
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2015
- Address: 222 THIRD STREET, SUITE 2240, CAMBRIDGE, MA, 02142
- Phone: 617-225-7700
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Joseph Baron | Director | Wellesley, MA |
| Jonathan Reis | Director | Wellesley, MA |
| Jonathan Reis | Executive Officer | Wellesley, MA |
| PINI ORBACH | Director | Watertown, MA |
| Chris Schelling | Director | Newton, MA |
| Chris Schelling | Executive Officer | Newton, MA |
Other filings by this issuer (1)
More